Add-on Acquisition • Life Science

Triphase Acquires Nereus Pharmaceuticals

On January 2, 2012, Triphase acquired life science company Nereus Pharmaceuticals

Acquisition Context

This is Triphase’s 1st transaction in the Life Science sector.
This is Triphase’s 1st transaction in the United States.
This is Triphase’s 1st transaction in California.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	January 2, 2012
Target	Nereus Pharmaceuticals
Sector	Life Science
Buyer(s)	Triphase
Deal Type	Add-on Acquisition

Target Company

Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals is a pioneer in the use of marine microbial sources for the discovery and follow-on development of new therapeutics for cancer and inflammatory and infectious diseases.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Triphase

Toronto, Ontario, Canada

Category	Company
Founded	2010
Sector	Life Science

DESCRIPTION

Triphase acquires promising cancer therapies and accelerates their development from pre-IND to clinical proof-of-concept leveraging our deep relationships with world-class scientists, clinicians, and business professionals with access to state-of-the-art facilities and capabilities. Triphase was founded in 2010 and is based in Toronto, Ontario.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2012	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2012 M&A